BioSeedin is planning a NEW column to share with you the vision and trend on the biopharma market. Today’s article is about the recent (three months) ADC related deals.
Vision: From ADC related deals to current trend
$43 billion’s buyout? Why does the ADC leading company Seagen worth so much to Pfizer? How could other biopharma companies react to the continuously raising ADC market? BioSeedin collected several recent ADC related deals to help in figuring out the reasons and the trend.
